AdvaMed

The leading voice for the medical technology community that provides life-changing innovations to millions of patients every day.

[AdvaMed @AdvaMedUpdate]

Medtech is an American success story—95 percent of R&D happens in the U.S., supporting 3 million jobs while driving innovation, exports, and healthier lives. We look forward to working with the Administration to keep Americans healthy. #MAHA #MedtechSaves

https://t.co/Bxc093cXRT

[AdvaMed @AdvaMedUpdate]

AdvaMed’s 2025 Annual Report is now available. The state of medtech is strong, and the patient impact is undeniable. Millions of lives are improved every day through innovations that enable earlier diagnosis, precise treatment, and minimally invasive care. https://t.co/sRw7P98qih

[AdvaMed @AdvaMedUpdate]

Agreed. As @ScottWhitakerMD wrote in his recent op-ed, Congress must pass the Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343 / S. 1717) so seniors aren't left waiting years for FDA-authorized breakthrough technologies.

https://t.co/lzBiaewXQW…

[MAHA Action @MAHA_Action]

People are dying and not being treated with up-to-date technology because of bureaucracy in the Medicare system.

Medicare coverage lags years behind FDA approval, meaning people are not getting the treatment they need and deserve.

The safety process for drugs and medical devices needs to be rigorous, but once something is proven safe, there is no reason patients shouldn’t have immediate access.

Lawmakers must act to prevent this from continuing.

[Scott Whitaker @ScottWMedTech]

Appreciate your support here. Medtech always has been and always will be all about Making Americans Healthy Again. Policy needs to keep up with our lifesaving industry. With this administration’s leadership, we can close this gap this year. #MAHA

[Jimmy Jeffries @jimmyjeffries]

Breakthroughs can't wait ...

[AdvaMed @AdvaMedUpdate]

The first edition of AdvaMed’s Insight Series features a Q&A with Melissa Cha (Amazon) and Taha Kass-Hout (GE HealthCare) on how AI is supporting clinicians and improving patient care. Hear from leaders in this space in upcoming editions of this series. https://t.co/bC7PHW7Gx1

[AdvaMed @AdvaMedUpdate]

@BDandCo is investing $110M to expand U.S. syringe production—driving innovation, strengthening supply chains, and accelerating delivery of biologic and GLP-1 therapies. Strong U.S. medtech keeps Americans healthy.

[BD @BDandCo]

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs; https://t.co/feRVwvkN9U

[AdvaMed @AdvaMedUpdate]

Atrial fibrillation affects 10.5M Americans and is often underdiagnosed. New digital health tech can detect AFib early so patients and doctors can act faster.

Read our guest blog by @OmronHealthUS Managing Director Alice Koehler to learn more:

https://t.co/lrucP1NQFg

[Scott Whitaker @ScottWMedTech]

Thank you for your leadership, and you are exactly right: The #medtech/#healthtech companies leading the #AI revolution need regulatory clarity as we revolutionize healthcare. Looking forward to continuing our work with you & your team on this. #MAHA

https://t.co/GzwuqBf3El

[AdvaMed @AdvaMedUpdate]

AdvaMed’s Imaging Division wrapped up RSNA 2025 by showcasing how we’re driving the future of medical imaging through innovation, advocacy, and collaboration. Advancing standards, safety, and technology across the medtech imaging ecosystem. #RSNA25

[AdvaMed @AdvaMedUpdate]

CMS released its 2026 Home Health Prospective Payment System final rule. AdvaMed will continue to work with CMS and remains committed to ensuring Medicare beneficiaries can access the life-saving medtech they need without delay.

https://t.co/jMrgVPBzzx

[Scott Whitaker @ScottWMedTech]

We couldn’t agree more, Dr. Oz—medtech is transforming patient care at a lightning pace. Medtech has been making Americans healthy again—and again and again—and we will continue to do so through innovations that increasingly put doctors and patients in the driver’s seat.

[AdvaMed @AdvaMedUpdate]

A study shows an AI-powered app can match human-led programs in helping people with diabetes manage weight, activity, and nutrition — highlighting how diabetes #medtech and digital health tech are expanding access to prevention and care.

https://t.co/VKrl3ZD8WC

[AdvaMed @AdvaMedUpdate]

AdvaMed applauds the introduction of the Health Technology Investment Act (H.R. 6197), supporting broader access to life-changing health tech. Thanks to @RepJohnJoyce, @RepSchneider, @RepScottPeters, @RepBethVanDuyne, @JayObernolte & @RepAngieCraig.

https://t.co/xlHkJJHUYl

[AdvaMed @AdvaMedUpdate]

We’re excited to share that AdvaMed’s Imaging division will be attending this year’s Radiological Society of North America (RSNA) 2025 in Chicago, where we’ll highlight how medtech innovation is transforming health care and saving lives. Visit Booth #5750 to connect. #RSNA25

[AdvaMed @AdvaMedUpdate]

This #DiabetesAwarenessMonth, we’re grateful to those ensuring students with diabetes can seamlessly use Continuous Glucose Monitors (CGMs) linked to their phones in schools. Medical exceptions to phone bans make it possible.

Learn more: https://t.co/lTD6ZvA4ZI

[Scott Whitaker @ScottWMedTech]

This #WorldDiabetesDay, AdvaMed staff wore blue to honor the 136 million Americans living with diabetes & prediabetes and our many member companies developing innovative medtech that empowers patients with real-time data, alerts, and insights to manage their diabetes.

[AdvaMed @AdvaMedUpdate]

Diabetes impacts more than 136 million Americans, including those with prediabetes. As America faces a chronic disease crisis, medtech continues to be a proven part of the solution, transforming how we detect, prevent and treat diabetes. #DiabetesAwareness https://t.co/ojoGrHUVi0

[AdvaMed @AdvaMedUpdate]

Congress has the chance to preserve Medicare beneficiary access to hundreds of lab tests. We were pleased to join 30 fellow organizations in urging passage of the RESULTS Act.

Read more: https://t.co/slQmDIrQxp

[AdvaMed @AdvaMedUpdate]

The Supreme Court’s latest rulings could reshape medtech and trade policy. Join Akin attorneys for a webinar, “Supreme Court Term in Review: Implications for the Medical Technology Industry,” on Nov. 18, 11 am–12 pm ET. Free for AdvaMed members: https://t.co/OmTcfyKKiT